---  
layout: startup_page  
title: "TORL BioTherapeutics"  
id: "torlbio.com"  
permalink: "/torlbiotherapeuticstorlbio.com04102024/"  
website: "https://torlbio.com/"  
funding_round: "Series B2"  
funding_amount: "$158M"  
investors: "Deep Track Capital, RA Capital Management, Perceptive Advisors, Avidity Partners, Goldman Sachs Alternatives, UC Investments, Bristol Myers Squibb, Vertex Ventures HC, Moore Strategic Ventures, Blue Owl Healthcare Opportunities, Perceptive Xontogeny Venture Fund"  
about: "TORL BioTherapeutics is a clinical-stage biotechnology company focused on discovering and developing antibody-based immunotherapies for cancer. They are developing a pipeline of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) targeting specific antigens overexpressed in cancer cells. Their work is based on a strategic partnership with the Slamon Research Lab at UCLA."  
markets: "Biotechnology, Oncology, Immunotherapy, Biopharma, Clinical Trials, Drug Discovery"  
hq: "Culver City, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/torl-biotherapeutics-llc"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/torl-biotherapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/523096-21"  

date_display: "10-Apr-2024"  
date: "2024-04-10"

# SEO Optimization  
meta_title: "TORL BioTherapeutics - Series B2 Funding ($158M)"  
meta_description: "TORL BioTherapeutics, TORL BioTherapeutics is a clinical-stage biotechnology company focused on discovering and developing antibody-based immunotherapies for cancer. They a..."  
meta_keywords: "TORL BioTherapeutics, Biotechnology, Oncology, Immunotherapy, Biopharma, Clinical Trials, Drug Discovery, Series B2 funding"  
canonical_url: "https://startup.projectstartups.com/torlbiotherapeuticstorlbio.com04102024/"  
---